This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2001;285:2317-2318.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Istanbul—The development of antimicrobial resistance by once-susceptible microbes apparently ranks with death and taxes as one of life's certainties. Meeting the global challenge posed by resistant microbes will require new drugs and new strategies for treating and preventing such infections, agreed delegates gathered for the 11th European Congress of Clinical Microbiology and Infectious Diseases.

A public health campaign in Belgium is taking aim at reducing inappropriate antibiotic use by the public and general practitioners. (Credit: Ministry of Social Affairs, Public Health and Environment. C. Decoster, editor)

Researchers noted that surveillance efforts are revealing an all-too-familiar scenario: increasing levels of antibiotic resistance in a variety of pathogens. In one study reported here, for example, researchers studying antimicrobial resistance in bacteria causing lower urinary tract infections (UTIs) found high levels of resistance to drugs traditionally used to treat such infections, said Gunnar Kahlmeter, MD, of Central Hospital . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001
Critchley et al.
J Antimicrob Chemother 2003;51:639-649.
ABSTRACT | FULL TEXT